In the news release, Biotech Pioneer Divine Skin Says Q3 Revenue Jumps to Roughly
, up 23% From Q3 and Soars 75% From Last Year, issued
by Divine Skin Inc. over PR Newswire, we are advised by the company that the headline and first paragraph, first sentence, should read "Q2" rather than "Q3" as originally issued inadvertently. The complete, corrected release follows:
Biotech Pioneer Divine Skin Says Q2 Revenue Jumps to Roughly $1.6 Million, up 23% From Q2 and Soars 75% From Last Year
MIAMI BEACH, Fla.
/PRNewswire-FirstCall/ -- Rapidly expanding biotech developer Divine Skin Inc. (OTC Bulletin Board: DSKX) announced preliminary Q2 numbers today:
or 23 percent above the previous quarter and 75 percent above Q3 of last year.
"Sustained growth over several quarters demonstrates the viability of our core principles of cutting-edge product development and absolute dedication to servicing our customers. We are also most excited about the release of Revita.COR conditioner which we believe establishes new possibilities in biotech development" said co-founder and chief executive
, whose company maintains edge-of-the art development of new molecules and therapies in the personal care sector. The company maintains its position as the world's innovator of hair re-growth technologies.
Revenue has been driven by new distribution and new products.
The Sigma Skin brand is already present in the majority of
stores, the premier luxury retailer in the
. The brand will continue to proliferate through the rest of the network as planned.
The DS Laboratories brand has continued to implement its deal with Fantastic Sams, stocking shelves and training employees for the chain of 1,300 franchised salons. DS Laboratories is on track to roll out in the rest of the chain by the end of the year. Demand has exceeded expectations through existing Fantastic Sams retail doors.